166 related articles for article (PubMed ID: 20338153)
1. Structural approach to the aging of phosphylated cholinesterases.
Masson P; Nachon F; Lockridge O
Chem Biol Interact; 2010 Sep; 187(1-3):157-62. PubMed ID: 20338153
[TBL] [Abstract][Full Text] [Related]
2. Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation.
Carletti E; Li H; Li B; Ekström F; Nicolet Y; Loiodice M; Gillon E; Froment MT; Lockridge O; Schopfer LM; Masson P; Nachon F
J Am Chem Soc; 2008 Nov; 130(47):16011-20. PubMed ID: 18975951
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
[TBL] [Abstract][Full Text] [Related]
4. Aging mechanism of butyrylcholinesterase inhibited by an N-methyl analogue of tabun: implications of the trigonal-bipyramidal transition state rearrangement for the phosphylation or reactivation of cholinesterases.
Nachon F; Carletti E; Worek F; Masson P
Chem Biol Interact; 2010 Sep; 187(1-3):44-8. PubMed ID: 20381476
[TBL] [Abstract][Full Text] [Related]
5. Pressure and propylene carbonate denaturation of native and "aged" phosphorylated cholinesterase.
Masson P; Gouet P; Clery C
J Mol Biol; 1994 May; 238(3):466-78. PubMed ID: 8176737
[TBL] [Abstract][Full Text] [Related]
6. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase.
Ekström F; Akfur C; Tunemalm AK; Lundberg S
Biochemistry; 2006 Jan; 45(1):74-81. PubMed ID: 16388582
[TBL] [Abstract][Full Text] [Related]
7. [Aging of cholinesterase after inhibition by organophosphates].
Curtil C; Masson P
Ann Pharm Fr; 1993; 51(2):63-77. PubMed ID: 8250487
[TBL] [Abstract][Full Text] [Related]
8. Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: the crystal structure suggests two alternative mechanisms of aging.
Nachon F; Asojo OA; Borgstahl GE; Masson P; Lockridge O
Biochemistry; 2005 Feb; 44(4):1154-62. PubMed ID: 15667209
[TBL] [Abstract][Full Text] [Related]
9. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
10. Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation.
Carletti E; Colletier JP; Dupeux F; Trovaslet M; Masson P; Nachon F
J Med Chem; 2010 May; 53(10):4002-8. PubMed ID: 20408548
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
12. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
13. Hydration change during the aging of phosphorylated human butyrylcholinesterase: importance of residues aspartate-70 and glutamate-197 in the water network as probed by hydrostatic and osmotic pressures.
Masson P; Cléry C; Guerra P; Redslob A; Albaret C; Fortier PL
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):361-9. PubMed ID: 10510301
[TBL] [Abstract][Full Text] [Related]
14. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
[TBL] [Abstract][Full Text] [Related]
15. Direct observation and elucidation of the structures of aged and nonaged phosphorylated cholinesterases by 31P NMR spectroscopy.
Segall Y; Waysbort D; Barak D; Ariel N; Doctor BP; Grunwald J; Ashani Y
Biochemistry; 1993 Dec; 32(49):13441-50. PubMed ID: 8257680
[TBL] [Abstract][Full Text] [Related]
16. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
17. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase.
Kovarik Z; Katalinić M; Sinko G; Binder J; Holas O; Jung YS; Musilova L; Jun D; Kuca K
Chem Biol Interact; 2010 Sep; 187(1-3):167-71. PubMed ID: 20206154
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.
Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H
Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909
[TBL] [Abstract][Full Text] [Related]
19. Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime.
Sanson B; Nachon F; Colletier JP; Froment MT; Toker L; Greenblatt HM; Sussman JL; Ashani Y; Masson P; Silman I; Weik M
J Med Chem; 2009 Dec; 52(23):7593-603. PubMed ID: 19642642
[TBL] [Abstract][Full Text] [Related]
20. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
